Clinical application of targeted next-generation sequencing utilizing bronchoalveolar lavage fluid in thoracic surgery ICU patients with suspected pulmonary infections
Journal of Applied Microbiology · 2025
DOI: 10.1093/jambio/lxae313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2025. Verfasst von Xiaobo Guo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi 777717, China. Hauptthemen laut MEDLINE: Bronchoalveolar Lavage Fluid, High-Throughput Nucleotide Sequencing, Intensive Care Units. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Air Force Medical University.
Themen: Intensivpflege
Abstract (Originalsprache)
Aims The aim of this prospective study was to evaluate the diagnostic value of targeted next-generation sequencing (tNGS) in identifying pathogens from bronchoalveolar lavage fluid (BALF) in thoracic surgery ICU patients, offering additional diagnostic methods for clinical practice. Methods and results We collected clinical data from patients with suspected pulmonary infections in the thoracic surgery ICU of the Second Affiliated Hospital of Air Force Medical University. A total of 50 patients were enrolled in this study. Traditional pathogen detection (TPD), involving culture and loop-mediated isothermal amplification assays for 12 pathogens, along with tNGS, was employed for pathogen identification in BALF samples. Our findings demonstrated that the positive rate of tNGS was significantly greater than that of TPD (96% vs. 68%). Among the 50 samples analyzed, tNGS identified a total of 165 pathogens, whereas TPD detected only 48 pathogens. The TPD method primarily detected bacteria and fungi, whereas tNGS exhibited broader capabilities, identifying 104 cases with bacteria, 19 with fungi, 34 with DNA viruses, and 8 with RNA viruses. Notably, tNGS displayed enhanced efficiency in detecting atypical pathogens such as fungi, DNA viruses and RNA viruses. Furthermore, compared with TPD, tNGS demonstrated superior sensitivity (95.83% vs. 68.75%). Conclusions tNGS technology, characterized by its high sensitivity, specificity, and cost-effectiveness, holds great promise as a reliable diagnostic tool for assessing pulmonary infections in the thoracic surgery ICU patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi 777717, China.
- Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, The State Key Laboratory of Neurology and Oncology Drug Development, Nanjing 210000, China.
Förderung
- Air Force Medical University
Zitieren
APA
Guo, X., Xie, N., Xi, X., Li, P., Jia, J., Chen, L., Ren, M., Wang, Y., Zhang, P., Deng, W., Wang, Y., Jing, P., Ding, R., & Gu, Z. (2025). Clinical application of targeted next-generation sequencing utilizing bronchoalveolar lavage fluid in thoracic surgery ICU patients with suspected pulmonary infections. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae313
Vancouver
Guo X, Xie N, Xi X, Li P, Jia J, Chen L, et al. Clinical application of targeted next-generation sequencing utilizing bronchoalveolar lavage fluid in thoracic surgery ICU patients with suspected pulmonary infections. Journal of Applied Microbiology. 2025. doi:10.1093/jambio/lxae313
BibTeX
@article{Guo2025,
author = {Guo, Xiaobo and Xie, Nianlin and Xi, Xiaotong and Li, Pei and Jia, Jianbo and Chen, Lianhong and Ren, Mingzhi and Wang, Yaping and Zhang, Peipei and Deng, Wanglong and Wang, Yan and Jing, Pengyu and Ding, Ran and Gu, Zhongping},
title = {Clinical application of targeted next-generation sequencing utilizing bronchoalveolar lavage fluid in thoracic surgery ICU patients with suspected pulmonary infections},
journal = {Journal of Applied Microbiology},
year = {2025},
doi = {10.1093/jambio/lxae313}
}
EUVIMED